The epidemiology of venous thromboembolism
RH White - Circulation, 2003 - Am Heart Assoc
Venous thromboembolism (VTE) occurs for the first time in≈ 100 persons per 100,000 each
year in the United States, and rises exponentially from< 5 cases per 100,000 persons< 15 …
year in the United States, and rises exponentially from< 5 cases per 100,000 persons< 15 …
[PDF][PDF] Guidelines on oral anticoagulation with warfarin
1.1 Žilní trombembolismus Cílová hodnota INR u první epizody žilního trombembolismu má
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …
Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline
Background The American College of Chest Physicians Clinical Practice Guideline on the
Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions …
Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions …
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
Einstein–PE Investigators - New England journal of medicine, 2012 - Mass Medical Soc
Background A fixed-dose regimen of rivaroxaban, an oral factor Xa inhibitor, has been
shown to be as effective as standard anticoagulant therapy for the treatment of deep-vein …
shown to be as effective as standard anticoagulant therapy for the treatment of deep-vein …
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial
Importance Although retrievable inferior vena cava filters are frequently used in addition to
anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is …
anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is …
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the …
Authors/Task Force Members, A Torbicki… - European heart …, 2008 - academic.oup.com
Document Reviewers: Jose-Luis Zamorano,(CPG Review Coordinator)(Spain), Felicita
Andreotti (Italy), Michael Ascherman (Czech Republic), George Athanassopoulos (Greece) …
Andreotti (Italy), Michael Ascherman (Czech Republic), George Athanassopoulos (Greece) …
Low-dose aspirin for preventing recurrent venous thromboembolism
TA Brighton, JW Eikelboom, K Mann… - … England Journal of …, 2012 - Mass Medical Soc
Background Patients who have had a first episode of unprovoked venous thromboembolism
have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective …
have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective …
Pleural diseases
RW Light - Evidence‐based Respiratory Medicine, 1995 - Wiley Online Library
Patients with primary pneumothorax are best initially treated with aspiration and, if this is
successful, hospitalization is usually not necessary. Patients with secondary pneumothorax …
successful, hospitalization is usually not necessary. Patients with secondary pneumothorax …
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines
This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …